ICU Income Tax Expense from 2010 to 2024

ICUI Stock  USD 163.96  4.21  2.64%   
ICU Medical's Income Tax Expense is decreasing with slightly volatile movements from year to year. Income Tax Expense is estimated to finish at about -46.2 M this year. For the period between 2010 and 2024, ICU Medical, Income Tax Expense quarterly trend regression had median of  12,296,000 and r-value of (0.66). View All Fundamentals
 
Income Tax Expense  
First Reported
1991-03-31
Previous Quarter
1.9 M
Current Value
15.1 M
Quarterly Volatility
4.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 240.2 M, Interest Expense of 107.9 M or Total Revenue of 2.4 B, as well as many indicators such as Price To Sales Ratio of 1.01, Dividend Yield of 0.0 or PTB Ratio of 1.08. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
  
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Latest ICU Medical's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of ICU Medical over the last few years. It is ICU Medical's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
       Timeline  

ICU Income Tax Expense Regression Statistics

Arithmetic Mean43,080
Coefficient Of Variation60,412
Mean Deviation21,196,560
Median12,296,000
Standard Deviation26,025,393
Sample Variance677.3T
Range73.4M
R-Value(0.66)
Mean Square Error409.7T
R-Squared0.44
Significance0.01
Slope(3,852,613)
Total Sum of Squares9482.5T

ICU Income Tax Expense History

2024-46.2 M
2023-48.6 M
2022-40.1 M
202120.1 M
202010.6 M
201913.7 M
2018-6.4 M

About ICU Medical Financial Statements

Investors use fundamental indicators, such as ICU Medical's Income Tax Expense, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Income Tax Expense-48.6 M-46.2 M

Currently Active Assets on Macroaxis

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Earnings Share
(4.55)
Revenue Per Share
96.302
Quarterly Revenue Growth
0.065
Return On Assets
0.0066
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.